Medical Cannabis in Arizona: Patient Characteristics, Perceptions, and Impressions of Medical Cannabis Legalization

Journal of Psychoactive Drugs

Volumn 47, Issue 4, 2015, Pages 259-266

  Troutt, William D ^a   DiDonato, Matthew D ^a  

^a Medical Marijuana Research Institute   (United States)

Author keywords

Arizona; medical cannabis; medical cannabis legalization; patient characteristics; perceptions

Indexed keywords

MEDICAL CANNABIS;

ADULT; AGED; ARTICLE; CANNABIS USE; DRUG EFFICACY; DRUG SAFETY; FEMALE; HUMAN; LIKERT SCALE; MAJOR CLINICAL STUDY; MALE; MEDICOLEGAL ASPECT; PATIENT ATTITUDE; POLICY; UNITED STATES; ADOLESCENT; ATTITUDE TO HEALTH; CANNABIS SMOKING; LEGISLATION AND JURISPRUDENCE; MIDDLE AGED; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ARIZONA; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; MALE; MARIJUANA SMOKING; MEDICAL MARIJUANA; MIDDLE AGED; YOUNG ADULT;

EID: 84944357315     PISSN: 02791072     EISSN: 21599777     Source Type: Journal    
DOI: 10.1080/02791072.2015.1074766     Document Type: Article

References (28)

1. S.K.Aggarwal,, G.T.Carter, M.D.Sullivan, C.Zubrunnen, R.Morrill, and J.D.Mayer. 2009. Characteristics of patients with chronic pain accessing treatment with medical cannabis in Washington State. Journal of Opioid Management 5 (5):257–86.
2. S.K.Aggarwal,, G.T.Carter, M.D.Sullivan, C.Zumbrunnen, R.Morrill, and J.D.Mayer. 2013. Prospectively surveying health-related quality of life and symptom relief in a lot-based sample of medical cannabis-using patients in urban Washington State reveals managed chronic illness and debility. American Journal of Hospice and Palliative Medicine 30 (6):523–31. doi:10.1177/1049909112454215.
3. J.R.Allegretti,, A.Courtwright, M.Lucci, J.R.Korzenik, and J.Levine. 2013. Marijuana use patterns among patients with inflammatory bowel disease. Inflammatory Bowel Diseases 19 (13):2809–14. doi:10.1097/01.MIB.0000435851.94391.37.
4. Anderson Robbins Research & Shaw & Company Research. 2013. Fox News poll: 85 percent of voters favor medical marijuana [survey report]. Fox News. http://www.foxnews.com/politics/interactive/2013/05/01/fox-news-poll-85-percent-voters-favor-medical-marijuana/
5. Arizona Department of Health Services. 2014. Arizona Medical Marijuana Act End of Year Report. http://www.azdhs.gov/medicalmarijuana/documents/reports/2014/arizona-medical-marijuana-end-of-year-report-2014.pdf
6. Arizona Department of Health Services Medical Marijuana Rules. 2012. http://www.azsos.gov/public_services/Title_09/9-17.htm
7. Associated Press-CNBC. 2010. AP-CNBC marijuana poll: Complete results & analysis. April 7-12, 2010 [Survey Report]. CNBC News. http://www.cnbc.com/id/36601126#
8. G.Aviello,, B.Romano, F.Borrelli, R.Capasso, L.Gallo, F.Piscitelli, V.Di Marzo, and A.A.Izzo. 2012. Chemopreventive effect of the non-psychotropic phytocannabinoid cannabidiol on experimental colon cancer. Journal of Molecular Medicine 90 (8):925–34. doi:10.1007/s00109-011-0856-x.
9. M.D.Bachhuber,, B.Saloner, C.O.Cunningham, and C.L.Barry. 2014. Medical cannabis laws and opioid analgesic overdose mortality in the United States, 1999-2010. Journal of the American Medical Association 174 (10):1668–73.
10. G.Bar-Sela,, M.Vorobeichik, S.Drawsheh, A.Omer, V.Goldberg, and E.Muller. 2013. The medical necessity for medicinal cannabis: Prospective, observational study evaluating the treatment in cancer patients on supportive or palliative care. Evidence-Based Complementary and Alternative Medicine 2013:1–8. doi:10.1155/2013/510392.
11. M.O.Bonn-Miller,, M.T.Boden, M.M.Bucossi, and K.A.Babson. 2014. Self-reported cannabis use characteristics, patterns and helpfulness among medical cannabis users. The American Journal of Drug and Alcohol Abuse 40 (1):23–30. doi:10.3109/00952990.2013.821477.
12. California Senate Bill 420. 2003. http://www.leginfo.ca.gov/pub/03-04/bill/sen/sb_0401-0450/sb_420_bill_20031012_chaptered.html
13. Colorado Department of Public Health and Environment. 2014. Medical Marijuana Registry Program Update. https://www.colorado.gov/pacific/sites/default/files/CHED_MMJ_06_2014_MMR_report.pdf
14. G.R.Greer,, C.S.Grob, and A.L.Halberstadt. 2014. PTSD symptom reports of patients evaluated for the New Mexico medical cannabis program. Journal of Psychoactive Drugs 46 (1):73–77. doi:10.1080/02791072.2013.873843.
15. C.E.Grella,, L.Rodriguez, and T.Kim. 2014. Patterns of medical marijuana use among individuals sampled from medical marijuana dispensaries in Los Angeles. Journal of Psychoactive Drugs 46 (4):263–72. doi:10.1080/02791072.2014.944960.
16. D.Harris,, R.T.Jones, R.Shank, R.Nath, E.Fernandez, K.Goldstein, and J.Mendelson. 2000. Self-reported marijuana effects and characteristics of 100 San Francisco medical marijuana club members. Journal of Addictive Diseases 19 (3):89–103. doi:10.1300/J069v19n03_07.
17. M.A.Ilgen,, K.Bohnert, F.Kleinberg, M.Jannausch, A.S.B.Bohnert, M.Walton, and F.C.Blow. 2013. Characteristics of adults seeking medical marijuana certification. Drug and Alcohol Dependence 132 (3):654–59. doi:10.1016/j.drugalcdep.2013.04.019.
18. W.Jiang,, Y.Zhang, L.Xiao, J.V.Cleemput, S.Ji, G.Bai, and X.Zhang. 2005. Cannabinoids promote embryonic and adult hippocampus neurogenesis and produce anxiolytic- and antidepressant-like effects. Journal of Clinical Investigation 115 (11):3104–16. doi:10.1172/JCI25509.
19. R.Lorenz, 2004. On the application of cannabis in paediatrics and epileptology. Neuro Endocrinology Letters 25 (1–2): 40–44.
20. M.E.Lynch,, and F.Campbell. 2011. Cannabinoids for treatment of chronic non-cancer pain: A systematic review of randomized trials. British Journal of Clinical Pharmacology 72 (5):735–44. doi:10.1111/j.1365-2125.2011.03970.x.
21. Montana Department of Public Health and Human Services. 2014. Montana Marijuana Program December 2014 Registry Information. http://dphhs.mt.gov/Portals/85/qad/documents/LicensureBureau/Marijuana%20Program/MMP%20Registry%20Information%20through%20December%2030%202014.pdf
22. R.Murphy, 2013. 2013 update: Michigan medical marijuana. http://marijuanapatients.org/michigan-comparison/
23. H.Nunberg,, B.Kilmer, R.L.Pacula, and J.R.Burgdorf. 2011. An analysis of applicants presenting to a medical marijuana specialty practice in California. Journal of Drug Policy Analysis 4 (1):1–16. doi:10.2202/1941-2851.1017.
24. T.J.O’Connell,, and C.B.Bou-Matar. 2007. Long term marijuana users seeking medical cannabis in California (2001-2007): Demographics, social characteristics, patterns of cannabis and other drug use of 4117 applicants. Harm Reduction Journal 4 (16). doi:10.1186/1477-7517-4-16.
25. A.Reiman, 2007. Medical cannabis patients: Patient profiles and health care utilization patterns. Complementary Health Practice Review 12 (1):31–50.
26. A.Reiman, 2009. Cannabis as a substitute for alcohol and other drugs. Harm Reduction Journal 6 (1):35. doi:10.1186/1477-7517-6-35.
27. C.Reinarman,, H.Nunberg, F.Lanthier, and T.Heddleston. 2011. Who are medical marijuana patients? Population characteristics from nine California assessment clinics. Journal of Psychoactive Drugs 43 (2):128–35. doi:10.1080/02791072.2011.587700.
28. S.Ryan-Ibarra,, M.Induni, and D.Ewing 2015. Prevalence of medical marijuana use in California, 2012. Drug and Alcohol Review 34 (2):141–146.